Low-Dose Alteplase During Primary Percutaneous Coronary Intervention According to Ischemic Time

BACKGROUND: Microvascular obstruction affects one-half of patients with ST-segment elevation myocardial infarction and confers an adverse prognosis. OBJECTIVES: This study aimed to determine whether the efficacy and safety of a therapeutic strategy involving low-dose intracoronary alteplase infused...

全面介紹

Na minha lista:
書目詳細資料
發表在:J Am Coll Cardiol
Main Authors: McCartney, Peter J., Maznyczka, Annette M., Eteiba, Hany, McEntegart, Margaret, Oldroyd, Keith G., Greenwood, John P., Maredia, Neil, Schmitt, Matthias, McCann, Gerry P., Fairbairn, Timothy, McAlindon, Elisa, Tait, Campbell, Welsh, Paul, Sattar, Naveed, Orchard, Vanessa, Corcoran, David, Ford, Thomas J., Radjenovic, Aleksandra, Ford, Ian, McConnachie, Alex, Berry, Colin
格式: Artigo
語言:Inglês
出版: Elsevier Biomedical 2020
主題:
Article
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC7109518/
https://ncbi.nlm.nih.gov/pubmed/32216909
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jacc.2020.01.041
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍